DXA assessment of the synergistic effects of long-term ipriflavone treatment and activities of daily living on bone mass in osteoporosis Sumio GotoMakoto KuriharaHideshige Moriya Section I: Orthopaedics Pages: S8 - S14
The effect of ipriflavone on bone mass of osteoporotic women: Single-agent and multi-agent combination ADFR therapy Hideaki KishimotoKichizo Yamamoto Section I: Orthopaedics Pages: S15 - S19
Effect of ipriflavone on bone mineral content in osteoporotic patients Toshitsugu SugimotoMasaaki FukaseTakuo Fujita Section II: Internal Medicine Pages: S22 - S25
Effect of ipriflavone on bone mineral density of lumbar spine of aged women Takami MikiHideyuki ArataniHirotoshi Morii Section II: Internal Medicine Pages: S26 - S29
Effects of 7-isopropoxy-3-phenyl-4H-1-benzopyran-4-one (ipriflavone) on serum levels of calcitonin and parathyroid hormone in patients with adult-onset diabetes Kiyoshi HashizumeKazuo IchikawaXiao-Yun Ma Section II: Internal Medicine Pages: S30 - S37
The influence of ipriflavone on bone metabolism and reduction of bone mineral density decrease by ipriflavone following menopause or bilateral oophorectomy Hiroaki OhtaShigeyuki KomukaiShiro Nozawa Section III: Obstetrics And Gynaecology Pages: S40 - S45
The effect of ipriflavone on osteopenia in ovariectomized women Itsuo GoraiOsamu ChakiHiroshi Minaguchi Section III: Obstetrics And Gynaecology Pages: S46 - S50
Recent findings in the diagnosis and prevention of osteoporosis Tetsuo Inoue Special Lecture: Reviews Pages: S52 - S58
Preventative treatment of involutional osteoporosis Hajime Orimo Special Lecture: Reviews Pages: S59 - S64
